AlphaMadera's AlphaVal page computes Macy's, Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag M as undervalued, fairly valued, or overvalued.

What is Macy's, Inc.'s fair value?

Fair value for M is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value M?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from M's most recent reported fundamentals.

M - Macy's, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $21.33 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Undervalued Moderate

Trading 29.6% below fair value

Current Price $23.76

Bear Case $29.52 24.2% upside ($29.52 - $23.76) / $23.76 = 24.2% $2.44 × 14x P/E

Fair Value $33.73 42.0% upside ($33.73 - $23.76) / $23.76 = 42.0% $2.44 × 16x P/E

Bull Case $37.95 59.7% upside ($37.95 - $23.76) / $23.76 = 59.7% $2.44 × 18x P/E

Adjust Assumptions

P/E Multiple

16.0x

Adjusted EPS

2.44$

Key Value Driver

Normalized P/E multiple (16x base case)

Implied Market Multiple 9.7x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $21.33 from 40 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $33.73 per share.

Warnings

ℹ Dividend-based valuation: $19.55 (below our primary estimate by 50%). Large gaps may signal the dividend doesn't reflect full earning power.

ℹ Wall Street's average price target is $21.33 (from 40 analysts). Our estimate is 83% above the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples